Nutrition giant Glanbia has told investors to expect higher profits this year, as demand for protein continues to soar.
A strong first half of revenue and volume growth across all three of Glanbia’s divisions saw sales jump $200m to $2.1bn (£1.6bn), an increase of 7%.
Group EBITDA accordingly swelled 14.1% to $275.4m in the half year to 4 July 2026.
Glanbia CEO Hugh McGuire said the performance reflected “disciplined execution” given ongoing whey cost inflation that affected its Performance Nutrition division.
Glanbia has also made progress on a group-wide transformation programme, through which it now expects to save $70m a year by 2027, up from its initial target of $60m.
“As a protein powerhouse at the heart of better nutrition, Glanbia is uniquely positioned to meet the growing demand for nutrition that supports healthier and more active lives,” McGuire said.
“We now expect adjusted EPS growth of 17% to 20% which will be driven by category and end-use consumer market demand and a strong operating performance across all three segments.”
Initial guidance for the year had been for EPS growth to come in at the upper end of 7%-11%.
No comments yet